Jane J. Zara

Array ( [id] => 6802518 [patent_doc_number] => 20030097683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Single-component RNA vectors derived from a virus and containing an intervening sequence between the cap and the 5\' end and able to replicate in a host plant cell within a host plant' [patent_app_type] => new [patent_app_number] => 10/200051 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11359 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20030097683.pdf [firstpage_image] =>[orig_patent_app_number] => 10200051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7357851 [patent_doc_number] => 20040014048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Antisense modulation of dual specific phosphatase 6 expression' [patent_app_type] => new [patent_app_number] => 10/199221 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014048.pdf [firstpage_image] =>[orig_patent_app_number] => 10199221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448370 [patent_doc_number] => 20040009899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Treating dominant disorders' [patent_app_type] => new [patent_app_number] => 10/195722 [patent_app_country] => US [patent_app_date] => 2002-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13970 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009899.pdf [firstpage_image] =>[orig_patent_app_number] => 10195722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892161 [patent_doc_number] => 07345025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells' [patent_app_type] => utility [patent_app_number] => 10/192980 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 34276 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345025.pdf [firstpage_image] =>[orig_patent_app_number] => 10192980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609366 [patent_doc_number] => 07994144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Process for the preparation of a composition of genetically modified hematopoietic progenitor cells' [patent_app_type] => utility [patent_app_number] => 10/483347 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 34297 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994144.pdf [firstpage_image] =>[orig_patent_app_number] => 10483347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683295 [patent_doc_number] => 20030119159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Aptamer capable of specifically adsorbing to Verotoxin-1 and method for obtaining the aptamer' [patent_app_type] => new [patent_app_number] => 10/189916 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4501 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119159.pdf [firstpage_image] =>[orig_patent_app_number] => 10189916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7365379 [patent_doc_number] => 20040005706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Antisense modulation of DEXRAS1 expression' [patent_app_type] => new [patent_app_number] => 10/185035 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005706.pdf [firstpage_image] =>[orig_patent_app_number] => 10185035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479304 [patent_doc_number] => 07223856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Antisense compounds which prevent cell death and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/185084 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 9810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223856.pdf [firstpage_image] =>[orig_patent_app_number] => 10185084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740764 [patent_doc_number] => 20030158133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases' [patent_app_type] => new [patent_app_number] => 10/175161 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37508 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158133.pdf [firstpage_image] =>[orig_patent_app_number] => 10175161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825290 [patent_doc_number] => 20030235912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Antisense modulation of orphan G-protein coupled receptor GPRC5B expression' [patent_app_type] => new [patent_app_number] => 10/177798 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30610 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235912.pdf [firstpage_image] =>[orig_patent_app_number] => 10177798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668299 [patent_doc_number] => 07094538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Diagnostic assay for cancer susceptibility' [patent_app_type] => utility [patent_app_number] => 10/166218 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5061 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094538.pdf [firstpage_image] =>[orig_patent_app_number] => 10166218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535842 [patent_doc_number] => 20020193289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression' [patent_app_type] => new [patent_app_number] => 10/165614 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13431 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193289.pdf [firstpage_image] =>[orig_patent_app_number] => 10165614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701635 [patent_doc_number] => 20030224515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antisense modulation of sterol regulatory element-binding protein-1 expression' [patent_app_type] => new [patent_app_number] => 10/161996 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33015 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224515.pdf [firstpage_image] =>[orig_patent_app_number] => 10161996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678547 [patent_doc_number] => 20030228688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Antisense modulation of isoprenylcysteine carboxyl methyltransferase expression' [patent_app_type] => new [patent_app_number] => 10/159834 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228688.pdf [firstpage_image] =>[orig_patent_app_number] => 10159834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701632 [patent_doc_number] => 20030224512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antisense modulation of beta-site APP-cleaving enzyme expression' [patent_app_type] => new [patent_app_number] => 10/159942 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224512.pdf [firstpage_image] =>[orig_patent_app_number] => 10159942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822070 [patent_doc_number] => 20030220231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth' [patent_app_type] => new [patent_app_number] => 10/151166 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14404 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220231.pdf [firstpage_image] =>[orig_patent_app_number] => 10151166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692565 [patent_doc_number] => 20030039997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Pentopyranosyl nucleic acid arrays, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/150402 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18414 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039997.pdf [firstpage_image] =>[orig_patent_app_number] => 10150402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822112 [patent_doc_number] => 20030220273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Antisense modulation of phosphodiesterase 4D expression' [patent_app_type] => new [patent_app_number] => 10/146860 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30971 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220273.pdf [firstpage_image] =>[orig_patent_app_number] => 10146860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821246 [patent_doc_number] => 20030219407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'RNA silencing in animals as an antiviral defense' [patent_app_type] => new [patent_app_number] => 10/150283 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12864 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219407.pdf [firstpage_image] =>[orig_patent_app_number] => 10150283 [rel_patent_id] =>[rel_patent_doc_number] =>)